Glucokinase (GK) plays a central role in the sensing of glucose in pancreatic β-cells and parenchymal cells of the liver. Glucokinase regulatory protein is a physiological inhibitor of GK in the liver. To understand the role of the interaction of these two proteins in glucose sensing, we carried out a series of experiments to localize the protein in the liver cell. The regulatory protein was found to be present mainly in the nucleus of the cell under a variety of conditions that mimicked the glucose status of the fed and fasted state. GK was localized in the nucleus when the cells were exposed to low glucose concentrations. At higher glucose concentrations or in the presence of low concentrations of fructose, GK translocated to the cytoplasm. The effect of fructose was more robust and rapid than the effect of high glucose concentrations. Furthermore, the effect of fructose and high glucose on the translocation of GK from the nucleus could be partially reversed by glucagon. This unusual localization and behavior suggests a role for GK and its regulatory protein in hepatic energy metabolism that may be broader than glucose phosphorylation.
Skip Nav Destination
Article navigation
Original Articles|
February 01 1997
Glucokinase Regulatory Protein May Interact With Glucokinase in the Hepatocyte Nucleus
Karen S Brown;
Karen S Brown
Departments of Metabolic Diseases, Bristol-Myers Squibb Pharmaceutical Research Institute
P.O. Box 4000, Princeton, NJ 08543
Search for other works by this author on:
Stephen S Kalinowski;
Stephen S Kalinowski
Departments of Metabolic Diseases, Bristol-Myers Squibb Pharmaceutical Research Institute
P.O. Box 4000, Princeton, NJ 08543
Search for other works by this author on:
John R Megill;
John R Megill
Experimental Pathology, Bristol-Myers Squibb Pharmaceutical Research Institute
P.O. Box 4000, Princeton, NJ 08543
Search for other works by this author on:
Stephen K Durham;
Stephen K Durham
Experimental Pathology, Bristol-Myers Squibb Pharmaceutical Research Institute
P.O. Box 4000, Princeton, NJ 08543
Search for other works by this author on:
Kasim A Mookhtiar
Kasim A Mookhtiar
Departments of Metabolic Diseases, Bristol-Myers Squibb Pharmaceutical Research Institute
P.O. Box 4000, Princeton, NJ 08543
Search for other works by this author on:
Address correspondence and reprint requests to Kasim A. Mookhtiar, Department of Metabolic Diseases, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, NJ 08543.
1
BSA, bovine serum albumin; ChoRE, carbohydrate response element; DMEM, Dulbecco's modified Eagle medium; F-l-P, fructose-1-phosphate; F-6-P, fructose-6-phosphate; FBS, fetal bovine serum; GK, glucokinase; GKRP, glucokinase regulatory protein; IBMX, isobutylmethylxanthine; KH, Krebs-Henseleit buffer; L-PK, liver type pyruvate kinase; MODY, maturity onset diabetes of the young; PBS, phosphate-buffered saline; SCD1, stearoyl CoA desaturase I.
Diabetes 1997;46(2):179–186
Article history
Received:
April 05 1996
Revision Received:
September 11 1996
Accepted:
September 11 1996
PubMed:
9000692
Citation
Karen S Brown, Stephen S Kalinowski, John R Megill, Stephen K Durham, Kasim A Mookhtiar; Glucokinase Regulatory Protein May Interact With Glucokinase in the Hepatocyte Nucleus. Diabetes 1 February 1997; 46 (2): 179–186. https://doi.org/10.2337/diab.46.2.179
Download citation file:
150
Views